期刊文献+

专利异议状况与药品经济价值的相关性研究 被引量:3

Correlation between Patent Opposition and the Economic Value of Drugs
原文传递
导出
摘要 目的:验证药品专利异议状况与药品经济价值之间的关联性,初步探索药品专利异议信息在药品经济价值评估中的应用。方法:利用SPSS统计软件,对美国食品与药品管理局《药品橙皮书》的498个药品的专利异议信息和药品经济价值信息进行卡方检验。结果与结论:药品专利异议状况与药品经济价值间具有关联性,专利异议信息在药品经济价值评估中具有广泛应用前景。 OBJECTIVE: To study the correlation between the patent opposition and the economic value of drugs and to explore the application of the patent opposition information in the evaluation of the economic values of drugs. METHODS: Using SPSS statistical software, Pearson Chisquared test was carried out on 498 drugs published in FDA's Drug Orange Book regarding the information of patent opposition and economic value drugs. RESULTS & CONCLUSIONS: A significant correlation was noted between patent opposition and economic value of drugs, and the prospect for the application of patent opposition information in the evaluation of economic value of drugs is quite promising.
出处 《中国药房》 CAS CSCD 北大核心 2007年第19期1449-1451,共3页 China Pharmacy
基金 澳门科学技术发展基金项目(049/2005/A-R1)
关键词 药品 专利异议 经济价值 评估 Drug Patent opposition Economic value Evaluation
  • 相关文献

参考文献8

  • 1Angell M.The Truth About the Drug Companies[M].New York:Random House,2004:20~ 22.
  • 2Harhoff D,Scherer FM,Vopel K.Citations,family size,opposition and the value of patent rights[J].Research Policy,2002,32(2):1 343.
  • 3Reitzig M.Valuing patents and patent portfolios from a corporate perspective-theoretical considerations,applied needs,and future challenges[A].Conference on intellectual assets:valuation and capitalization[C].Geneva:United Nations,2003:66~ 82.
  • 4Reitzig M.Improving patent valuation methods for management-validating new indicators by analyzing application rationales[J].Research Policy,2004,33(6):939.
  • 5Lanjouw JO,Schankerman M.Patent quality and research productivity-measuring innovation with multiple indicators[J].The Economic Journal,2004,114(4):441.
  • 6U.S.Food and Drug Administration.Orange book[EB/OL].http://www.fda.gov/cder/orange.2006.2007,2,20.
  • 7European Patent Office.International Patent Documentation Centre[EB/OL].http://ep.espacenet.com.2006.2007,2,20.
  • 8上海医药工业研究院.中国医药数字图书馆[EB/OL].http://www.pharmadl.com.2006.2007,2,20.

同被引文献23

  • 1李国春.SPSS语句窗口编程在Ridit分析中的应用[J].中国卫生统计,2004,21(3):187-187. 被引量:4
  • 2刁天喜,王松俊.医药情报研究实践——新药项目筛选与评估[J].中华医学图书情报杂志,2005,14(1):4-6. 被引量:9
  • 3曹巍,李清华,雷霆,吴乐山.国际“重磅药品”标准演变分析及我国“重磅药品”标准探析[J].中华医学科研管理杂志,2006,19(4):208-211. 被引量:1
  • 4徐伟.专利到期药舒马普坦的国内专利分析[J].中国医药工业杂志,2007,38(5). 被引量:3
  • 5U.S. Food and Drug Administration. Food and drug administration modernization act[EB/OL ]. http://www.fda. gov/Regulatorylnformation/Legislation/FederalFoodDrug- andCosmeticActFDCAct/SignificantAmendmentstotheFD- CAct/FDAMA/FullTextofFDAMAlaw/default.htm.2009 - 10-22.2010-11-24.
  • 6Harhoff D, Scherer FM, Vopel K. Citations, family size, opposition and the value of patent rights[J]. Research Policy,2002, 32(2):1 343.
  • 7Reitzig M. Valuing patents and patent portfolios from a corporate perspective-theoretical considerations, applied needs, and future challenges[C]. Conference on intellectual assets: valuation and capitalization. Geneva: United Nations, 2003: 66-82.
  • 8U.S. Food and Drug Administration. Orange book[EB/OL]. http ://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. 2010-10-14.2010-11-24.
  • 9European Patent Office. International Patent Documentation Centre[EB/OL ].http : / /www.epo.org/patents/patentin-formation/raw-data.html.2010-11-23.2010-11-24.
  • 10Cook T. Pharmaceutical patent litigation in Europe[J]. Expert Opinion on Therapeutic Patents, 1999, 9(2) : 181.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部